United States
Germany
Japan
United Kingdom
China
ASB11 (NM_080873) Human Tagged ORF Clone Lentiviral Particle
CAT＃: RC210162L4V
- LentiORF®
-
Lenti ORF particles, ASB11 (mGFP-tagged)-Human ankyrin repeat and SOCS box containing 11 (ASB11), transcript variant 1, 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 9,120.00
货期*
详询
规格
Product images
经常一起买 (3)
Specifications
| Product Data | |
| Product Name | ASB11 (NM_080873) Human Tagged ORF Clone Lentiviral Particle |
| Vector | pLenti-C-mGFP-P2A-Puro |
| ACCN | NM_080873 |
| ORF Size | 969 bp |
| Sequence Data |
The ORF insert of this clone is exactly the same as(RC210162).
|
| OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
| OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
| Reference Data | |
| RefSeq | NM_080873.2 |
| RefSeq Size | 2799 bp |
| RefSeq ORF | 972 bp |
| Locus ID | 140456 |
| Protein Families | Druggable Genome, Transmembrane |
| MW | 35.4 kDa |
| Gene Summary | The protein encoded by this gene is a member of the ankyrin repeat and SOCS box-containing (ASB) family of proteins. They contain ankyrin repeat sequence and SOCS box domain. The SOCS box serves to couple suppressor of cytokine signalling (SOCS) proteins and their binding partners with the elongin B and C complex, possibly targeting them for degradation. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2011] |
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
You may also need
Customer
Reviews
Loading...
